Biotech Rally: Artelo (ARTL) Gains On Strong Preclinical Results
Artelo Biosciences, Inc. (NASDAQ: ARTL) had a significant uptick in the most recent trading session, as its shares closed at $14.32, up 42.49%. This notable rising trend followed the presentation of positive preclinical results about its experimental antidepressant drug, ART12.11, at a prestigious scientific conference. Innovative Results at the ICRS Symposium New preclinical findings for […]